1) rapamycin
雷帕霉素
1.
Application of rapamycin to the treatment for chronic kidney diseases;
雷帕霉素在慢性肾脏疾病治疗中的应用
2.
Inhibition effect of rapamycin on acute graft-versus-host disease after allogeneic bone marrow transplantation in a murine model;
雷帕霉素抑制小鼠骨髓移植后移植物抗宿主病作用的初步研究
3.
Effects of rapamycin on the expression of VEGF after corneal transplantation;
雷帕霉素对角膜移植术后VEGF表达的影响
2) Sirolimus
雷帕霉素
1.
Effects of Sirolimus on Proliferation and Differentation of Rat Smooth Muscle Progenitor Cells in Vitro;
雷帕霉素对大鼠骨髓源平滑肌祖细胞增殖及分化的影响
2.
The Efficacy of Sirolimus-eluting Stents and Bear Metal Stents in Treatment of Atherosclerotic Coronary Lesion;
雷帕霉素涂层支架与裸金属支架对冠脉病变的疗效
3.
One-Year Outcomes of Biodegradable Polymer Sirolimus-Eluting Stents for Patients With Coronary Artery Disease:Pilot Registry From a China Single Center;
国产生物降解涂层雷帕霉素洗脱支架置入术治疗冠心病一年结果：国内首项单中心注册研究
3) Rapamycin(RAPA)
雷帕霉素(RAPA)
4) mTOR
雷帕霉素靶蛋白
1.
Effect of antisense mTOR gene mediated by nanoparticles on neointimal formation in vein graft in rats;
纳米粒子包载反义雷帕霉素靶蛋白基因转染对移植静脉内膜增生的影响
2.
Objective To study the effect of antisense mTOR gene transfection mediated by nanoparticles(NP) on intimal perliferation after vein grafting.
目的观察以纳米粒子为载体的外源性反义雷帕霉素靶蛋白(mTOR)基因局部转染对移植静脉内膜增生的影响。
3.
Objective:To study the effect of antisense mTOR gene transfection on neointimal formation in rat vein grafts.
目的:观察反义雷帕霉素靶蛋白(mTOR)基因转染对移植静脉内膜增生的影响。
5) mammalian target of rapamycin
雷帕霉素靶蛋白
1.
Observation of mammalian target of rapamycin in EC9706 and Eca109;
EC9706和Eca109细胞中雷帕霉素靶蛋白信号通路激活状态观察
2.
Expression of mammalian target of rapamycin and p70 S6 kinase in rabbit periodontal tissues remodeling during orthodontic tooth movement;
正畸力作用下兔牙周组织中雷帕霉素靶蛋白和核糖体蛋白S6激酶的表达
3.
[Purpose] To study activation of mammalian target of rapamycin(mTOR) signaling pathway in esophageal squamous cell carcinoma cell lines EC9706 and Eca109.
[目的]研究雷帕霉素靶蛋白(mTOR)信号传导通路在食管鳞癌细胞系EC9706和Eca109中的激活状态。
6) rapamycin/pharmacology
雷帕霉素/药理学
补充资料：雷帕霉素
分子式：C51H79NO13
分子量：暂无
CAS号：53123-88-9
性质：暂无
制备方法：暂无
用途：免疫抑制剂。
分子量：暂无
CAS号：53123-88-9
性质：暂无
制备方法：暂无
用途：免疫抑制剂。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条